175 related articles for article (PubMed ID: 21298467)
1. Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients.
Parker LA; Porta M; Lumbreras B; López T; Guarner L; Hernández-Aguado I; Carrato A; Corominas JM; Rifà J; Fernandez E; Alguacil J; Malats N; Real FX
Eur J Epidemiol; 2011 Mar; 26(3):229-36. PubMed ID: 21298467
[TBL] [Abstract][Full Text] [Related]
2. How useful is it clinically to analyse the K-ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta-analysis.
Parker LA; Lumbreras B; Lopez T; Hernández-Aguado I; Porta M
Eur J Clin Invest; 2011 Jul; 41(7):793-805. PubMed ID: 21391995
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of K-ras gene mutation detection and cytology in pancreatic juice in the diagnosis and screening of pancreatic cancer.
Boadas J; Mora J; Urgell E; Puig P; Roca M; Cussó X; Capellà G; Lluís F; Farré A
Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1153-9. PubMed ID: 11711770
[TBL] [Abstract][Full Text] [Related]
4. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer.
Urgell E; Puig P; Boadas J; Capellà G; Queraltó JM; Boluda R; Antonijuan A; Farré A; Lluís F; González-Sastre F; Mora J
Eur J Cancer; 2000 Oct; 36(16):2069-75. PubMed ID: 11044643
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses.
Villanueva A; Reyes G; Cuatrecasas M; Martínez A; Erill N; Lerma E; Farré A; Lluís F; Capellá G
Gastroenterology; 1996 May; 110(5):1587-94. PubMed ID: 8613066
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of organochlorine compounds and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.
Porta M; Malats N; Jariod M; Grimalt JO; Rifà J; Carrato A; Guarner L; Salas A; Santiago-Silva M; Corominas JM; Andreu M; Real FX
Lancet; 1999 Dec 18-25; 354(9196):2125-9. PubMed ID: 10609819
[TBL] [Abstract][Full Text] [Related]
8. [Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].
Dai MH; Zhao YP; Cai LX; Zhu Y
Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):332-5. PubMed ID: 12892584
[TBL] [Abstract][Full Text] [Related]
9. Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer.
Futakawa N; Kimura W; Yamagata S; Zhao B; Ilsoo H; Inoue T; Sata N; Kawaguchi Y; Kubota Y; Muto T
J Hepatobiliary Pancreat Surg; 2000; 7(1):63-71. PubMed ID: 10982594
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
11. Mutational activation of K-ras in nonneoplastic exocrine pancreatic lesions in relation to cigarette smoking status.
Berger DH; Chang H; Wood M; Huang L; Heath CW; Lehman T; Ruggeri BA
Cancer; 1999 Jan; 85(2):326-32. PubMed ID: 10023699
[TBL] [Abstract][Full Text] [Related]
12. Occupational exposure to dyes, metals, polycyclic aromatic hydrocarbons and other agents and K-ras activation in human exocrine pancreatic cancer.
Alguacil J; Porta M; Kauppinen T; Malats N; Kogevinas M; Carrato A;
Int J Cancer; 2003 Nov; 107(4):635-41. PubMed ID: 14520703
[TBL] [Abstract][Full Text] [Related]
13. Identification of K-ras mutations in pancreatic juice in the early diagnosis of pancreatic cancer.
Berthélemy P; Bouisson M; Escourrou J; Vaysse N; Rumeau JL; Pradayrol L
Ann Intern Med; 1995 Aug; 123(3):188-91. PubMed ID: 7598300
[TBL] [Abstract][Full Text] [Related]
14. Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.
Theodor L; Melzer E; Sologov M; Idelman G; Friedman E; Bar-Meir S
Dig Dis Sci; 1999 Oct; 44(10):2014-9. PubMed ID: 10548352
[TBL] [Abstract][Full Text] [Related]
15. Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.
Lu X; Xu T; Qian J; Wen X; Wu D
Chin Med J (Engl); 2002 Nov; 115(11):1632-6. PubMed ID: 12609076
[TBL] [Abstract][Full Text] [Related]
16. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
Banerjee SK; Makdisi WF; Weston AP; Campbell DR
Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
[TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
18. K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis.
Wenger FA; Zieren J; Peter FJ; Jacobi CA; Müller JM
Langenbecks Arch Surg; 1999 Apr; 384(2):181-6. PubMed ID: 10328172
[TBL] [Abstract][Full Text] [Related]
19. Occupational exposure to organic solvents and K-ras mutations in exocrine pancreatic cancer.
Alguacil J; Porta M; Malats N; Kauppinen T; Kogevinas M; Benavides FG; Partanen T; Carrato A;
Carcinogenesis; 2002 Jan; 23(1):101-6. PubMed ID: 11756230
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
